scispace - formally typeset
R

Ravi R. Thiagarajan

Researcher at Boston Children's Hospital

Publications -  298
Citations -  21078

Ravi R. Thiagarajan is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Extracorporeal membrane oxygenation & Extracorporeal. The author has an hindex of 59, co-authored 262 publications receiving 17413 citations. Previous affiliations of Ravi R. Thiagarajan include University of Washington & Stony Brook University.

Papers
More filters
Journal ArticleDOI

Factors Associated With Prolonged Recovery After the Fontan Operation

TL;DR: High volume expansion in the early postoperative period is an independent risk factor for prolonged recovery and may represent the compound effects of multiple risk factors including preoperative hemodynamics and a marked systemic inflammatory response to surgery and cardiopulmonary bypass, which in turn may mediate prolonged recovery.
Journal ArticleDOI

Utilizing a Collaborative Learning Model to Promote Early Extubation Following Infant Heart Surgery

TL;DR: A collaborative learning strategy designed clinical practice guideline significantly increased the rate of early extubation with no change in the rates of reintubation and did not significantly change postoperative ICU length of stay.
Journal ArticleDOI

Extracorporeal membrane oxygenation in patients undergoing superior cavopulmonary anastomosis.

TL;DR: Mortality in infants with Glenn physiology supported with ECMO is lower than that previously reported, but the incidence of neurologic injury is high, and data support use of ECMO in patients with Glen physiology with refractory cardiopulmonary failure.
Journal ArticleDOI

Impact of ABO-Incompatible Listing on Wait-List Outcomes Among Infants Listed for Heart Transplantation in the United States A Propensity Analysis

TL;DR: The proportion of US infants listed for an ABO-I heart transplantation has risen dramatically in recent years but still appears to be preferentially used for sicker infant candidates, and the A BO-I listing strategy is associated with a higher likelihood of transplantation within 30 days for infants with blood group O and may benefit a broader range of transplants candidates.